Cost of active ACC claims for deep vein thrombosis caused by medical treatment in New Zealand
Year ended June 2011–2018, NZD millions
Year ended June | NZD |
---|---|
2011 | 197,900 |
2012 | 321,278 |
2013 | 178,352 |
2014 | 153,526 |
2015 | 136,576 |
2016 | 199,728 |
2017 | 297,307 |
2018 | 344,785 |